STAT+: A scrap of data on Amgen’s obesity drug candidate wipes out $12 billion in market value

STAT November 12, 2024
Elaine Chen

The market move is a reminder of the precarious nature of the stock ahead of a critical readout

On Tuesday, a tiny shred of data on Amgen’s lead obesity candidate — not yet verified — erased $12 billion in market value.

The data, spotted by an analyst at...

Today's Sponsors

Today's Sponsor